ANTIDIABETIC AGENT COMPRISING ANIONIC POLYAMINO ACID-METAL COMPLEX

摘要

It is intended to provide an agent for treating diabetes, particularly an agent for treating diabetes capable of being administered orally, which has high safety even if it is administered for a long period of time. The invention relates to a pharmaceutical composition for treating or preventing diabetes comprising an anionic polyamino acid, preferably a metal-polyamino acid complex which can be produced from poly-gamma-glutamic acid and a metal compound. More particularly, the invention relates to the pharmaceutical composition for treating or preventing diabetes comprising an anionic polyamino acid, preferably a metal-polyamino acid complex which can be produced from poly-gamma-glutamic acid and a metal compound and having at least one action of a hypoglycemic action, a glucose tolerance improving action, a blood pressure-lowering action and an insulin resistance improving action. Further, the invention relates to a food composition comprising an anionic polyamino acid, preferably a metal-polyamino acid complex which can be produced from poly-gamma-glutamic acid and a metal compound.